Search

Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Research Manitoba, Boehringer Ingelheim Canada and First Nations Health and Social Secretariat of Manitoba Announce Chronic Kidney Disease Screening Program in the Manitoba Adult First Nations Population

Vancouver General Hospital pilots new plant-rich menu items for health of patients and planet

Research Manitoba and Boehringer Ingelheim Canada Partnership to Invest in Diabetes Care in Indigenous Populations in Manitoba

University Health Network and Boehringer Ingelheim Canada partner to impact patients lives and help a healthcare system under strain

Health Canada approves NexGard® and NexGard Spectra™ for the reduction of Lyme disease

New collaboration between Boehringer Ingelheim and Sleip leverages AI technology to help detect lameness in horses

Virtual care pharmacy services offered in Alberta long-term care facilities

Using AI to transform screening for type 2 diabetes

Ensho Health

Boehringer Ingelheim Canada, community cardiologists, and Ensho Health collaborated to create a tool optimizing care for chronic conditions in Alberta. More info.

Vancouver Coastal Health

VCH collaborates with Boehringer Ingelheim Canada's team to expedite healthcare solutions, enhance health outcomes, and drive sustainable change. Read more.

Aservo™ EquiHaler™, industry-first therapy for severe equine asthma, now available in Canada

New initiative helps over 16,000 healthcare providers gain critical knowledge about palliative care during COVID-19

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development

Indigenous Peoples living with diabetes is the focus of four new health pilot projects in Ontario, Nunavut, Alberta, and Manitoba 

New health projects empower Indigenous communities to address chronic diseases

Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats

Boehringer Ingelheim (Canada) Ltd. partners with LMC Healthcare on national diabetes prevention program

University of Guelph’s Dr. Charlotte Winder named 2023 Metacam® 20 Bovine Welfare Award winner

Alberta’s Dr. Karen Schwartzkopf-Genswein named 2022 Metacam® 20 Bovine Welfare Award winner

Award recognizes outstanding contributions to the welfare of animals in Canada

New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec

The project will use artificial intelligence (A.I.), wearable technologies and electronic health record systems to identify patients who may have type 2 diabetes in Montreal, Quebec

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years Human Pharma pipeline acceleration: up to 15 new product launches

Introducing Ingelvac Provenza™ — Stop influenza A Virus in swine where it starts

Boehringer Ingelheim Animal Health introduces Ingelvac® MycoMAX in Canada — the first and only commercially available swine vaccine for Mycoplasma hyorhinis

Life forward - Boehringer Ingelheim unveils its evolved company brand

Ingelheim, Germany, 30/10/2023 | Boehringer Ingelheim, a leading research-driven biopharmaceutical company, on Monday presented a new corporate branding that is designed to inspire deeper connection with the company’s diverse customers, partners

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers

Search

Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Research Manitoba, Boehringer Ingelheim Canada and First Nations Health and Social Secretariat of Manitoba Announce Chronic Kidney Disease Screening Program in the Manitoba Adult First Nations Population

Vancouver General Hospital pilots new plant-rich menu items for health of patients and planet

Research Manitoba and Boehringer Ingelheim Canada Partnership to Invest in Diabetes Care in Indigenous Populations in Manitoba

University Health Network and Boehringer Ingelheim Canada partner to impact patients lives and help a healthcare system under strain

Health Canada approves NexGard® and NexGard Spectra™ for the reduction of Lyme disease

New collaboration between Boehringer Ingelheim and Sleip leverages AI technology to help detect lameness in horses

Virtual care pharmacy services offered in Alberta long-term care facilities

Using AI to transform screening for type 2 diabetes

Ensho Health

Vancouver Coastal Health

Aservo™ EquiHaler™, industry-first therapy for severe equine asthma, now available in Canada

New initiative helps over 16,000 healthcare providers gain critical knowledge about palliative care during COVID-19

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development

Indigenous Peoples living with diabetes is the focus of four new health pilot projects in Ontario, Nunavut, Alberta, and Manitoba

New health projects empower Indigenous communities to address chronic diseases

Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats

Boehringer Ingelheim (Canada) Ltd. partners with LMC Healthcare on national diabetes prevention program

University of Guelph’s Dr. Charlotte Winder named 2023 Metacam® 20 Bovine Welfare Award winner

Alberta’s Dr. Karen Schwartzkopf-Genswein named 2022 Metacam® 20 Bovine Welfare Award winner

New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

Introducing Ingelvac Provenza™ — Stop influenza A Virus in swine where it starts

Boehringer Ingelheim Animal Health introduces Ingelvac® MycoMAX in Canada — the first and only commercially available swine vaccine for Mycoplasma hyorhinis

Life forward - Boehringer Ingelheim unveils its evolved company brand

Indigenous Peoples living with diabetes is the focus of four new health pilot projects in Ontario, Nunavut, Alberta, and Manitoba 

Alberta’s Dr. Karen Schwartzkopf-Genswein named 2022 Metacam® 20 Bovine Welfare Award winner